Raily Aesthetic Medicine International Holdings Limited (HK:2135) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Raily Aesthetic Medicine International Holdings Limited has announced a provision for asset impairment totaling approximately RMB47.1 million, primarily due to the cessation of its subsidiary’s involvement in distributing e-PTFE facial implants. This move is expected to decrease the company’s total profit and net profit attributable to owners by around RMB45.0 million for the year ending December 2024. The board has deemed the impairment provision necessary to accurately reflect the company’s financial standing.
For further insights into HK:2135 stock, check out TipRanks’ Stock Analysis page.